Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies.

MLA

Ferreira, Joaquim J., et al. “Opicapone for the Treatment of Early Wearing-off in Levodopa-Treated Parkinson’s Disease: Pooled Analysis of Patient Level Data from Two Randomized Open-Label Studies.” Journal of Neurology, vol. 271, no. 10, Oct. 2024, pp. 6729–38. EBSCOhost, https://doi.org/10.1007/s00415-024-12614-8.

APA

Ferreira, J. J., Lee, J.-Y., Ma, H.-I., Jeon, B., Poewe, W., Antonini, A., Stocchi, F., Rodrigues, D. M., Fonseca, M. M., Castilla-Fernández, G., Holenz, J., Rocha, J.-F., & Rascol, O. (2024). Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson’s disease: pooled analysis of patient level data from two randomized open-label studies. Journal of Neurology, 271(10), 6729–6738. https://doi.org/10.1007/s00415-024-12614-8

Chicago

Ferreira, Joaquim J, Jee-Young Lee, Hyeo-Il Ma, Beomseok Jeon, Werner Poewe, Angelo Antonini, Fabrizio Stocchi, et al. 2024. “Opicapone for the Treatment of Early Wearing-off in Levodopa-Treated Parkinson’s Disease: Pooled Analysis of Patient Level Data from Two Randomized Open-Label Studies.” Journal of Neurology 271 (10): 6729–38. doi:10.1007/s00415-024-12614-8.